Literature DB >> 23507281

Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.

Hui Xin Ong1, Daniela Traini, Mary Bebawy, Paul M Young.   

Abstract

Ciprofloxacin is a well-established broad-spectrum fluoroquinolone antibiotic that penetrates well into the lung tissues; still, the mechanisms of its transepithelial transport are unknown. The contributions of specific transporters, including multidrug efflux transporters, organic cation transporters, and organic anion-transporting polypeptide transporters, to the uptake of ciprofloxacin were investigated in vitro using an air interface bronchial epithelial model. Our results demonstrate that ciprofloxacin is subject to predominantly active influx and a slight efflux component.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507281      PMCID: PMC3716180          DOI: 10.1128/AAC.00306-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.

Authors:  A F Barker; L Couch; S B Fiel; M H Gotfried; J Ilowite; K C Meyer; A O'Donnell; S A Sahn; L J Smith; J O Stewart; T Abuan; H Tully; J Van Dalfsen; C D Wells; J Quan
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

2.  The distribution of the anti-HIV drug, 2'3'-dideoxycytidine (ddC), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors.

Authors:  J E Gibbs; S A Thomas
Journal:  J Neurochem       Date:  2002-02       Impact factor: 5.372

3.  Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.

Authors:  K I Hirsch-Ernst; C Ziemann; I Rustenbeck; G F Kahl
Journal:  Toxicology       Date:  2001-10-05       Impact factor: 4.221

4.  Expression of MRP1 and related transporters in human lung cells in culture.

Authors:  T Lehmann; C Köhler; E Weidauer; C Taege; H Foth
Journal:  Toxicology       Date:  2001-10-05       Impact factor: 4.221

5.  Systemic exposure, tissue distribution, and disease evolution of a high solubility ciprofloxacin-aluminum complex in a murine model of septicemia induced by salmonella enterica serotype Enteritidis.

Authors:  Susana Andrea Breda; Maria Laura Guzmán; Alejandra Confalonieri; Claudia González; Monica Sparo; Ruben Hilario Manzo; Sergio Sánchez Bruni; Maria Eugenia Olivera
Journal:  Mol Pharm       Date:  2013-01-11       Impact factor: 4.939

6.  Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats.

Authors:  Neil R Mathia; Julita Timoszyk; Paul I Stetsko; John R Megill; Ronald L Smith; Doris A Wall
Journal:  J Drug Target       Date:  2002-02       Impact factor: 5.121

7.  P-glycoprotein efflux pump expression and activity in Calu-3 cells.

Authors:  K O Hamilton; G Backstrom; M A Yazdanian; K L Audus
Journal:  J Pharm Sci       Date:  2001-05       Impact factor: 3.534

8.  Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.

Authors:  R Ohashi; I Tamai; J Nezu Ji; H Nikaido; N Hashimoto; A Oku; Y Sai; M Shimane; A Tsuji
Journal:  Mol Pharmacol       Date:  2001-02       Impact factor: 4.436

9.  Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.

Authors:  Hui Xin Ong; Daniela Traini; David Cipolla; Igor Gonda; Mary Bebawy; Helen Agus; Paul M Young
Journal:  Pharm Res       Date:  2012-07-26       Impact factor: 4.200

10.  Effect of cisplatin-induced acute renal failure on bioavailability and intestinal secretion of quinolone antibacterial drugs in rats.

Authors:  Hiroaki Yamaguchi; Ikuko Yano; Hideyuki Saito; Ken-ichi Inui
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

View more
  7 in total

1.  In Vitro Mechanistic Study of the Distribution of Lascufloxacin into Epithelial Lining Fluid.

Authors:  Kouhei Ohya; Junichi Takano; Shigeru Manita
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.

Authors:  Ching-Yee Loo; Wing-Hin Lee; Gianluca Lauretani; Santo Scalia; David Cipolla; Daniela Traini; Paul Young; Hui Xin Ong
Journal:  Pharm Res       Date:  2018-02-07       Impact factor: 4.200

3.  Potent Antiedematous and Protective Effects of Ciprofloxacin in Pulmonary Ricinosis.

Authors:  Yoav Gal; Anita Sapoznikov; Reut Falach; Sharon Ehrlich; Moshe Aftalion; Tamar Sabo; Chanoch Kronman
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

4.  Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model.

Authors:  Guihong Chai; Heejun Park; Shihui Yu; Fanfan Zhou; Jian Li; Qingguo Xu; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2019-08-12       Impact factor: 5.875

5.  Dendrimer nanocarriers for transport modulation across models of the pulmonary epithelium.

Authors:  Balaji Bharatwaj; Abdul Khader Mohammad; Radovan Dimovski; Fernando L Cassio; Reinaldo C Bazito; Denise Conti; Qiang Fu; Joshua Reineke; Sandro R P da Rocha
Journal:  Mol Pharm       Date:  2015-02-17       Impact factor: 4.939

6.  A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection.

Authors:  Muhammad W Sadiq; Elisabet I Nielsen; Dalia Khachman; Jean-Marie Conil; Bernard Georges; Georges Houin; Celine M Laffont; Mats O Karlsson; Lena E Friberg
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-08-30       Impact factor: 2.745

7.  Detemplated and Pillared 2-Dimensional Zeolite ZSM-55 with Ferrierite Layer Topology as a Carrier for Drugs.

Authors:  Weronika Strzempek; Aleksandra Korzeniowska; Andrzej Kowalczyk; Wieslaw J Roth; Barbara Gil
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.